Your partners in health.
Developing new life changing medicines.
Our business is
taking care of you.
Medicine
Modern Research
Innovative thinking
We think outside the box using modern techniques to analyze data to find a cure.
When life is uncertain
We are confident
Villya is constantly working to search for direct causes in a world of uncertainty.
Pharmaceuticals
Action
We are developing pharmaceuticals that are meant to cure not treat putting us out front.
Liquid Praziquantel
Patent pending
Our scientist have made a break through discovery that will allow children to have access to this life saving drug.
Liquid Praziquantel is not only easily administered orally but it now can be accurately dosed in a ml solution, no more guessing by breaking large pills. Villya's new form of Praziquantel is not only liquid it is more effective as it is water-soluble and is combined with other ingredients to help eliminate the toxicity of the dying parasites from the patients body.
Worlds First View of Water Soluble liquid Praziquantel.
Villasel
U.S. Pat. No. 10,857,151
A drug for Female Vaginal Schistosomiasis (FGS)
Our research has led Villya to the discovery that Female Vaginal Schistosomiasis is a disease having its own biome and needs to be treated as such. Oral Praziquantel does not have the power to penetrate this alone so we have developed our new drug Villasel. This drug works as a topical gel administered directly to the sight of the infection clearing the parasites. Villya designed this drug specifically to eliminate the threat so we combined our two active ingredients to eliminate not only the adult worms but the juveniles and egg!
By eliminating the cause of FGS we are able to save the patient from cervical cancer related to FGS and HIV exposure.
For treatment of Schistosomiasis intrauterine. When schistosomiasis resides beyond the cervix in females and needs to be treated Inlasel can be used to treat schistosomiasis.
